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a 6-to-12-month duration of ef-
fect, oligonucleotide therapeutics 
might become competitive not 
only with biologics, but also with 
orally administered drugs, an out-
come that was unforeseeable only 
a short while ago. Of course, the 
future of inclisiran and oligonu-
cleotide therapeutics is complete-
ly dependent on the demonstra-
tion of their safety.
Conjugated oligonucleotides are 
chemically defined “large small 
molecules” that can be synthe-
sized in an advanced oligonucle-
otide lab within a day. They are 
assembled from standard build-
ing blocks, phosphoramidites, in 
an automatic fashion using solid-
phase chemistry. The cost of oli-
gonucleotides is driven mainly by 
the cost of its precursors and is 
expected to be in the low hun-
dreds of dollars per gram on a 
commercial scale. With a yearly 
dose of 300 to 500 mg, the manu-
facturing cost for this class of 
drugs is on par with that of small-
molecule drugs and is probably 
much lower than that of mono-
clonal antibodies. Although the 
manufacturing cost accounts for 
only a minority of the initial 
market price of the drug, the 
relative simplicity of the manu-
facturing process and the room-
temperature stability of the dried 
oligonucleotides, which can be 
brought to solution at the point 
of care, might eventually make 
this class of therapeutics widely 
available for a broad population.
Disclosure forms provided by the author 
are available at NEJM.org.
From RNA Therapeutics Institute, Program 
in Molecular Medicine, University of Massa-
chusetts Medical School, Worcester. 
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A View from the Edge — Creating a Culture of Caring
Rana L.A. Awdish, M.D. 
In 2008, an occult adenoma in my liver ruptured, and I effec-
tively bled to death in my own 
hospital. I lost my entire blood 
volume into my abdomen, trigger-
ing what’s known in trauma as 
the Triad of Death — a kind of 
suicidal spiral of the blood in 
which it becomes too acidic and 
too cold to clot. I would receive 
more than 26 units of blood 
products that night — packed 
red cells, platelets, cryoprecipitate, 
fresh frozen plasma. I would go 
into multisystem organ failure, 
my liver and kidneys would shut 
down, I would be put on a venti-
lator, have a stroke and a com-
plete hemodynamic collapse. The 
baby I was 7 months pregnant 
with would not survive, but I 
would — thanks to the incredi-
ble skill and grace of the teams of 
professionals who cared for me.
My recovery involved five major 
operations including a right hep-
atectomy. I had to relearn to walk, 
speak, and do many other things 
I had taken for granted. But in the 
process, as a patient, I learned 
things about us — physicians 
and other medical professionals 
— that I might not have wanted 
to know. I learned that though 
we do so many difficult, technical 
things so perfectly right, we fail 
our patients in many ways.
As a patient, I was privy to 
failures that I’d been blind to as a 
clinician. There were disturbing 
deficits in communication, unco-
ordinated care, and occasionally 
an apparently complete absence of 
empathy. I recognized myself in 
every failure.
When I overheard a physician 
describe me as “trying to die on 
us,” I was horrified. I was not try-
ing to die on anyone. The descrip-
tion angered me. Then I cringed. 
I had said the same thing, often 
and thoughtlessly, in my training. 
“He was trying to die on me.” As 
critical care fellows, we had all 
said it. Inherent in that accusa-
tion was our common attribution 
of intention to patients: we sub-
consciously constructed a narra-
tive in which the doctor–patient 
relationship was antagonistic. It 
was one of many revelatory mo-
ments for me.
I heard my colleagues say 
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things to me in ways that inflict-
ed more suffering, even when 
they believed they were helping.
“We’re going to have to find 
you a new liver, unless you want 
to live here forever.”
“Are you sure your pain is an 
eight? I just gave you morphine 
an hour ago.”
“You should hold the baby,” 
someone said. “I don’t want to 
be graphic, but after a few days 
in the morgue, their skin starts to 
break down and you won’t be able 
to anymore, even if you change 
your mind.”
Small things would gut me. 
Receiving a bill for the attempted 
resuscitation of the baby, for ex-
ample. My husband took on the 
task of reconciling the bill with 
the lack of a baby. The billing de-
partment explained that the bill 
was generated when we had 
failed to enroll her in our insur-
ance plan. No one could explain, 
of course, at what exact juncture 
we should have called our insur-
ance company, seeing as how 
she’d never technically been alive. 
It took four phone calls to settle 
the charges. A trivial oversight, 
by a department ostensibly not 
involved in patient care, had the 
potential to bring me to my knees.
My experience changed me. It 
changed my vision of what I want-
ed our organization to be, to em-
body. I wanted the value of empa-
thetic, coordinated care to spread 
through our system. I shared my 
story openly. I wanted the system 
leaders and every employee to 
know that everything matters, 
always. Every person, every time.
How do you build and main-
tain a culture of shared purpose 
in the infinitely complex arena of 
health care? How do you ensure 
that you engender in employees a 
dedication and commitment to 
doing what’s right? Identifying 
the gaps between the stated mis-
sion and values of an institution 
and its actual delivery of care is 
critical. As systems, we have to 
recognize and acknowledge our 
mistakes, our shortcomings, just 
as individual physicians do. We 
need to reflect on times when 
our care has deviated from what 
we intended — when we haven’t 
been who we hoped to be. We 
have to be transparent and allow 
the failure to reshape us, to help 
us reset our intention and mold 
our future selves.
Bravely, my institution respond-
ed to my experience by radically 
revising the way in which we in-
troduce every new employee to our 
organizational culture — collo-
quially referred to as “onboard-
ing.” Our institutional leaders had 
already launched a “Culture of 
Caring” curriculum for nursing. 
But they understood that to truly 
change the culture, all new em-
ployees, including physicians, 
needed to internalize our institu-
tion’s values. So they expanded 
their efforts, incorporating the 
failures and successes of my pa-
tient story to illuminate our 
shared purpose and build an en-
gaged culture.
Through the training that was 
developed, participants learn to 
articulate their purpose as dis-
tinct from their job. Transporters 
hear how meaningful it was to 
me when one of their own — 
having seen me break down when 
questioned by someone in radiol-
ogy — took it upon himself to 
warn the technicians performing 
various tests not to ask about the 
baby whose small pink wristband 
was still in my chart. He asked 
his colleagues to do the same. In 
an 800-bed hospital, the trans-
porters had united to form a pro-
tective enclosure around one pa-
tient.
Similarly, radiology technicians 
learn what a kindness it was that 
they stopped trying to awaken my 
exhausted husband to move him 
from my bedside for my portable 
x-ray, instead throwing a lead 
cover over him and letting him 
sleep. The power of these stories 
shows new employees that they 
have a purpose and that they are 
valued.
In addition, new employees 
are taught to recognize different 
forms of suffering: avoidable and 
unavoidable. Our goal is to find 
ways to mitigate suffering by re-
As a patient, I was privy to failures  
that I’d been blind to as a clinician.  
There were disturbing deficits in  
communication, uncoordinated care,  
and occasionally an apparently complete  
absence of empathy. I recognized
myself in every failure.
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sponding to the unavoidable kind 
with empathy and by improving 
our processes and procedures to 
avoid inflicting the avoidable kind 
whenever possible.
Our failures are analyzed, and 
our successes shared. Consider the 
power of that choice. Early on, 
all new employees hear about how 
we recognize and admit to our 
failures. How we partner to en-
sure that transparency keeps us 
from repeating our errors. How 
we hold each other accountable. 
By illuminating our failures, we 
can begin an authentic conversa-
tion about shared purpose, resil-
ience, and building an engaged 
culture.
We believe that by focusing on 
our missteps, we can ensure that 
the path ahead is one of compas-
sionate, coordinated care. When 
we are ashamed, we can’t tell our 
stories. They become inaccessible 
to us. In the wake of painful ex-
perience, we all seek meaning. It 
is the human thing to do, but 
it is also the job of great organi-
zations. The stories we tell do 
more than restore our faith in 
ourselves. They have the power 
to transform.
Disclosure forms provided by the author 
are available at NEJM.org.
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